• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数对尿路上皮癌患者术后的预后价值:一项系统评价与Meta分析

The Prognostic Value of Body Mass Index in Patients With Urothelial Carcinoma After Surgery: A Systematic Review and Meta-Analysis.

作者信息

Yang Zhiqiang, Bai Yunjin, Hu Xu, Wang Xiaoming, Han Ping

机构信息

Department of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

West China School of Medicine/West China Hospital, Sichuan University, Chengdu, People's Republic of China.

出版信息

Dose Response. 2020 Dec 15;18(4):1559325820979247. doi: 10.1177/1559325820979247. eCollection 2020 Oct-Dec.

DOI:10.1177/1559325820979247
PMID:33402880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7745568/
Abstract

BACKGROUND

The clinical evidence of body mass index (BMI) for survival has increased in urothelial carcinoma (UC). This study aimed to investigate the prognostic value of BMI on the oncologic outcomes of patients with UC after surgery.

METHODS

The systematic review and meta-analysis was performed using Pubmed, Embase and Cochrane Library. We collected hazard ratio (HR) and 95% confidence interval (CI) on cancer specific survival (CSS), overall survival (OS) and recurrence-free survival (RFS) from the studies including upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of bladder (UCB).

RESULTS

A total of 13 studies comprising over 12,200 patients were enrolled in the quantitative synthesis. Compared with normal weight, overweight was associated with better CSS (HR = 0.87, 95% CI: 0.79-0.95) and RFS (HR = 0.86, 95% CI: 0.78-0.96). Meanwhile, we found that obese patients had worse CSS (HR = 1.14, 95%CI: 1.03-1.26), OS (HR = 1.31, 95% CI: 1.19-1.44) and RFS (HR = 1.24, 95% CI: 1.12-1.37). We observed that underweight was associated with inferior CSS (HR = 1.87, 95% CI: 1.54-2.26) in UTUC patients.

CONCLUSIONS

Overweight was a protective factor for patients with UC after surgery, while obesity and underweight predicted unfavorable survival. Individual BMI may be considered for prognostication after surgeries and patient stratification for clinical trials.

摘要

背景

体重指数(BMI)对尿路上皮癌(UC)患者生存影响的临床证据日益增多。本研究旨在探讨BMI对UC患者术后肿瘤学结局的预后价值。

方法

通过PubMed、Embase和Cochrane图书馆进行系统评价和荟萃分析。我们从包括上尿路尿路上皮癌(UTUC)和膀胱尿路上皮癌(UCB)的研究中收集癌症特异性生存(CSS)、总生存(OS)和无复发生存(RFS)的风险比(HR)及95%置信区间(CI)。

结果

共有13项研究纳入了超过12,200例患者进行定量综合分析。与正常体重相比,超重与更好的CSS(HR = 0.87,95% CI:0.79 - 0.95)和RFS(HR = 0.86,95% CI:0.78 - 0.96)相关。同时,我们发现肥胖患者的CSS(HR = 1.14,95%CI:1.03 - 1.26)、OS(HR = 1.31,95% CI:1.19 - 1.44)和RFS(HR = 1.24,95% CI:1.12 - 1.37)较差。我们观察到体重过轻与UTUC患者较差的CSS(HR = 1.87,95% CI:1.54 - 2.26)相关。

结论

超重是UC患者术后的一个保护因素,而肥胖和体重过轻则预示着不良生存结局。术后预后评估及临床试验患者分层时可考虑个体BMI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/77bf5f5ee4ea/10.1177_1559325820979247-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/4493f112d52d/10.1177_1559325820979247-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/1bc13ff2c250/10.1177_1559325820979247-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/49171ccedf8b/10.1177_1559325820979247-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/77bf5f5ee4ea/10.1177_1559325820979247-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/4493f112d52d/10.1177_1559325820979247-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/1bc13ff2c250/10.1177_1559325820979247-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/49171ccedf8b/10.1177_1559325820979247-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5518/7745568/77bf5f5ee4ea/10.1177_1559325820979247-fig4.jpg

相似文献

1
The Prognostic Value of Body Mass Index in Patients With Urothelial Carcinoma After Surgery: A Systematic Review and Meta-Analysis.体重指数对尿路上皮癌患者术后的预后价值:一项系统评价与Meta分析
Dose Response. 2020 Dec 15;18(4):1559325820979247. doi: 10.1177/1559325820979247. eCollection 2020 Oct-Dec.
2
Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.体重指数对接受根治性手术治疗的上、下尿路癌患者肿瘤学结局的影响:一项多机构回顾性研究。
Asia Pac J Clin Oncol. 2018 Aug;14(4):310-317. doi: 10.1111/ajco.12848. Epub 2018 Apr 6.
3
Decreased Preoperative Serum AGR as a Diagnostic Marker of Poor Prognosis after Radical Surgery of Upper Urinary Tract and Bladder Cancers from a Pooled Analysis of 9,002 Patients.术前血清 AGR 降低可作为上尿路上皮癌和膀胱癌根治性手术后不良预后的诊断标志物:一项纳入 9002 例患者的汇总分析。
Dis Markers. 2022 Sep 5;2022:6575605. doi: 10.1155/2022/6575605. eCollection 2022.
4
Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.马兜铃酸相关的泌尿道癌:手术风险和肿瘤学结局的最新荟萃分析以及对人类研究中观察到的分子改变的系统评价
Ther Adv Drug Saf. 2021 Mar 21;12:2042098621997727. doi: 10.1177/2042098621997727. eCollection 2021.
5
The prognostic value of sarcopenia in patients with surgically treated urothelial carcinoma: A systematic review and meta-analysis.肌少症对接受手术治疗的尿路上皮癌患者的预后价值:系统评价和荟萃分析。
Eur J Surg Oncol. 2019 May;45(5):747-754. doi: 10.1016/j.ejso.2019.03.003. Epub 2019 Mar 7.
6
Lymph node dissection for upper tract urothelial carcinoma: A systematic review.上尿路尿路上皮癌的淋巴结清扫术:一项系统评价。
Arab J Urol. 2020 Jul 27;19(1):37-45. doi: 10.1080/2090598X.2020.1791563.
7
Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis.腹腔镜与开放肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局:更新的荟萃分析。
World J Surg Oncol. 2021 Apr 21;19(1):129. doi: 10.1186/s12957-021-02236-z.
8
High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis.高全身免疫炎症指数预示着尿路上皮癌患者的预后不良及对膀胱内卡介苗治疗的反应:一项系统评价和荟萃分析。
Front Oncol. 2023 Nov 1;13:1229349. doi: 10.3389/fonc.2023.1229349. eCollection 2023.
9
Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.根治性肾输尿管切除术治疗上尿路上皮癌患者术前淋巴细胞相关系统性炎症生物标志物的预后价值:系统评价和荟萃分析。
World J Surg Oncol. 2020 Oct 23;18(1):273. doi: 10.1186/s12957-020-02048-7.
10
The Prevalence and Prognostic Role of PD-L1 in Upper Tract Urothelial Carcinoma Patients Underwent Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.PD-L1在上尿路尿路上皮癌患者接受根治性肾输尿管切除术中的患病率及预后作用:一项系统评价和荟萃分析
Front Oncol. 2020 Aug 21;10:1400. doi: 10.3389/fonc.2020.01400. eCollection 2020.

引用本文的文献

1
Navigating the obesity paradox in bladder cancer prognosis-insights from the Taiwan National Health Insurance System Database.探索膀胱癌预后中的肥胖悖论——来自台湾国民健康保险系统数据库的见解
Front Nutr. 2024 Dec 11;11:1433632. doi: 10.3389/fnut.2024.1433632. eCollection 2024.
2
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights.植物代谢物作为乳腺癌的调节剂:对机制见解的综合综述。
Med Oncol. 2024 Jan 3;41(2):45. doi: 10.1007/s12032-023-02269-2.
3
The Prognostic Role of Body Mass Index on Oncological Outcomes of Upper Tract Urothelial Carcinoma.

本文引用的文献

1
The Effect of an Abnormal BMI on Orthopaedic Trauma Patients: A Systematic Review and Meta-Analysis.异常体重指数对骨科创伤患者的影响:一项系统评价和荟萃分析。
J Clin Med. 2020 May 1;9(5):1302. doi: 10.3390/jcm9051302.
2
Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy.不同种族人群体重指数对根治性肾输尿管切除术治疗上尿路上皮癌影响的差异。
World J Urol. 2021 Feb;39(2):491-500. doi: 10.1007/s00345-020-03204-0. Epub 2020 Apr 21.
3
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
体重指数对上尿路尿路上皮癌肿瘤学结局的预后作用
Cancers (Basel). 2023 Nov 10;15(22):5364. doi: 10.3390/cancers15225364.
4
Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review.上尿路尿路上皮癌根治性肾输尿管切除术后的肿瘤学结局:文献综述
Transl Androl Urol. 2023 Aug 31;12(8):1351-1362. doi: 10.21037/tau-22-882. Epub 2023 Jul 28.
5
Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid.具有马兜铃酸的复发性尿路上皮癌的突变特征和克隆相关性。
Front Oncol. 2022 Sep 14;12:990023. doi: 10.3389/fonc.2022.990023. eCollection 2022.
6
Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center.代谢综合征能否作为上尿路尿路上皮癌生存结果的预测指标?一项在中国大型中心进行的倾向评分匹配研究。
Front Oncol. 2022 May 26;12:816915. doi: 10.3389/fonc.2022.816915. eCollection 2022.
7
Associations between body mass index and bladder cancer survival: Is the obesity paradox short-lived?体重指数与膀胱癌生存率之间的关联:肥胖悖论是否短暂存在?
Can Urol Assoc J. 2022 May;16(5):E261-E267. doi: 10.5489/cuaj.7546.
BMI 对接受帕妥珠单抗和/或曲妥珠单抗-美坦新偶联物治疗的 HER2+转移性乳腺癌患者的影响。真实世界证据。
J Cell Physiol. 2020 Nov;235(11):7900-7910. doi: 10.1002/jcp.29445. Epub 2020 Jan 15.
4
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
5
BMI is associated with FEV decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials.BMI 与慢性阻塞性肺疾病的 FEV 下降相关:临床试验的荟萃分析。
Respir Res. 2019 Oct 29;20(1):236. doi: 10.1186/s12931-019-1209-5.
6
Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma.体重指数对上尿路尿路上皮癌手术治疗人群中肿瘤特征及生存的影响及其作用
Curr Urol. 2019 Jul;12(4):201-209. doi: 10.1159/000499305. Epub 2019 Jul 20.
7
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.肥胖在泌尿生殖系统肿瘤中的关键作用,重点关注尿路上皮癌和前列腺癌。
Cancers (Basel). 2019 Aug 22;11(9):1225. doi: 10.3390/cancers11091225.
8
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.体质量指数(BMI)、BMI 变化与小细胞肺癌和非小细胞肺癌患者的总生存:国际肺癌研究联合会的一项汇总分析。
J Thorac Oncol. 2019 Sep;14(9):1594-1607. doi: 10.1016/j.jtho.2019.05.031. Epub 2019 Jun 1.
9
The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline.体重指数与肾癌风险之间的关联:一项按照PRISMA指南进行的更新剂量反应荟萃分析。
Medicine (Baltimore). 2018 Nov;97(44):e12860. doi: 10.1097/MD.0000000000012860.
10
Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.体重指数对根治性膀胱切除术后临床结局参数、并发症发生率及生存率的影响:一项欧洲前瞻性多中心研究的证据
Urol Int. 2018;101(1):16-24. doi: 10.1159/000488466. Epub 2018 May 2.